Infectious Disease In Vitro Diagnostics Market Analysis Covering Growth Drivers And Future Outlook

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Infectious Disease In Vitro Diagnostics Market Be By 2030 Compared To Its 2026 Market Size?

The infectious disease in vitro diagnostics market has experienced significant growth over recent years. Its size is projected to expand from $15.1 billion in 2025 to $16.13 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.8%. Historically, this growth has been driven by factors such as the global infectious disease burden, the expansion of hospital laboratories, the increasing demand for early diagnosis, advancements in immunoassays, and various government disease control programs.

The infectious disease in vitro diagnostics market size is anticipated to experience robust expansion over the coming years. This market is projected to reach $21.25 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth during the forecast period include pandemic preparedness initiatives, the proliferation of molecular diagnostics, increasing antimicrobial resistance, the expansion of diagnostic laboratories, and heightened healthcare screening. Key developments expected during this period involve the widespread adoption of rapid molecular diagnostics, point of care infectious testing, the development of high sensitivity pathogen detection methods, the use of multiplex diagnostic panels, and a rise in surveillance testing.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30303&type=smp

Which Key Factors Are Driving The Infectious Disease In Vitro Diagnostics Market Growth?

The heightened worldwide occurrence of infectious diseases stimulated the expansion of the infectious disease in vitro diagnostics market over the historical timeframe. Infectious diseases denote the count of people globally grappling with bacterial, viral, fungal, or parasitic infections at any given moment, reflecting the total disease load across populations. Changes in climate have broadened the natural environments for vectors like mosquitoes that carry diseases, contributing to an escalation in the worldwide spread of infectious diseases. The infectious disease in vitro diagnostics facilitate this progression by offering accurate and prompt diagnostic instruments, empowering healthcare professionals to pinpoint pathogens, commence suitable treatment, and manage outbreaks with greater efficiency. As an illustration, in October 2024, the World Health Organization, a health authority situated in Switzerland, reported that approximately 10.8 million people globally were infected with tuberculosis, comprising 55% being men, 33% women, and 12% children and adolescents, while those afflicted with human immunodeficiency virus (HIV) constituted 6.1% of cases. Consequently, the rising global prevalence of infectious diseases propelled the expansion of the infectious disease in vitro diagnostics market throughout the historic period.

Which Segment Categories Are Included In The Infectious Disease In Vitro Diagnostics Market Segment Analysis?

The infectious disease in vitro diagnostics market covered in this report is segmented –

1) By Product Type: Instruments, Reagents, Software And Services

2) By Technology: Molecular Diagnostics, Immunoassay, Microbiology

3) By Application: Methicillin-Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Respiratory Virus, Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB), Gonorrhea, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Hepatitis C, Hepatitis B, Other Applications

4) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Instrument: Polymerase Chain Reaction Machines, Immunoassay Analyzers, Microbiology Analyzers, Next Generation Sequencers

2) By Reagent: Molecular Reagents, Immunoassay Reagents, Microbiology Reagents, Enzymes And Buffers, Controls And Calibrators

3) By Software And Services: Data Management Software, Laboratory Information Systems, Cloud Based Solutions, Maintenance And Support Services, Consulting And Training Services

Which Trends Are Guiding The Direction Of The Infectious Disease In Vitro Diagnostics Market?

Leading companies in the infectious disease in vitro diagnostics market are concentrating on developing innovative products, such as solutions for the rapid detection of multiple gastrointestinal pathogens, to facilitate timely diagnoses, enhance patient outcomes, and expand point-of-care testing capabilities. The rapid detection of multiple gastrointestinal pathogens refers to diagnostic tests designed to quickly identify several disease-causing microorganisms within the gastrointestinal tract from a single sample. As an illustration, in June 2024, MP Biomedicals, a US-based provider offering a diverse array of products, chemicals, and diagnostics, launched a series of immunochromatographic-based rapid diagnostic kits specifically for gastrointestinal infectious diseases. These kits enable the quick and accurate identification of Helicobacter pylori, Salmonella typhi, and Vibrio cholerae serogroups O1 and O139. Key features of these kits include rapid, point-of-care qualitative detection, versatility in sample usage (covering stool, blood, plasma, serum, water, and food), and applicability across both clinical and research environments. By harnessing cutting-edge immunochromatographic technology, they assist in early diagnosis, monitoring the effectiveness of treatment, and confirming pathogen eradication, thereby signifying a notable advancement in gastrointestinal health diagnostics through their combination of speed, precision, and extensive pathogen coverage.

Who Are The Active Companies Shaping The Infectious Disease In Vitro Diagnostics Market?

Major companies operating in the infectious disease in vitro diagnostics market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, bioMérieux SA, QIAGEN N.V., Becton Dickinson and Company, Hologic Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Revvity Inc., OraSure Technologies Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries Ltd., Bio-Rad Laboratories Inc., Trivitron Healthcare

Get The Full Infectious Disease In Vitro Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/global-infectious-disease-in-vitro-diagnostics-market-report

Where Is The Infectious Disease In Vitro Diagnostics Market Primarily Concentrated By Region?

North America was the largest region in the infectious disease in vitro diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Infectious Disease In Vitro Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=30303&type=smp

Browse Through More Reports Similar to the Global Infectious Disease In Vitro Diagnostics Market 2026, By The Business Research Company

Cogeneration Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cogeneration-equipment-global-market-report

Sterilization Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/sterilization-equipment-global-market-report

Respiratory Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795